請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41387
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 廖淑貞(Shwu-Jen Liaw) | |
dc.contributor.author | Hao-Hui Chen | en |
dc.contributor.author | 陳顥輝 | zh_TW |
dc.date.accessioned | 2021-06-15T00:17:51Z | - |
dc.date.available | 2011-10-07 | |
dc.date.copyright | 2011-10-07 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011-08-15 | |
dc.identifier.citation | 1.Allison, C., N. Coleman, P. L. Jones, and C. Hughes. 1992. Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Infect Immun 60:4740-4746.
2.Allison, C., L. Emody, N. Coleman, and C. Hughes. 1994. The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. J Infect Dis 169:1155-1158. 3.Allison, C., and C. Hughes. 1991. Bacterial swarming: an example of prokaryotic differentiation and multicellular behaviour. Sci Prog 75:403-422. 4.Bahrani, F. K., G. Massad, C. V. Lockatell, D. E. Johnson, R. G. Russell, J. W. Warren, and H. L. Mobley. 1994. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun 62:3363-3371. 5.Braun, V., and T. Focareta. 1991. Pore-forming bacterial protein hemolysins (cytolysins). Crit Rev Microbiol 18:115-158. 6.Bryan, L. E., and S. Kwan. 1983. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother 23:835-845. 7.Bryan, L. E., and H. M. Van Den Elzen. 1977. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother 12:163-177. 8.Carlioz, A., and D. Touati. 1986. Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life? EMBO J 5:623-630. 9.Chattopadhyay, M. K., C. W. Tabor, and H. Tabor. 2003. Polyamines protect Escherichia coli cells from the toxic effect of oxygen. Proc Natl Acad Sci U S A 100:2261-2265. 10.Chou, H. T., D. H. Kwon, M. Hegazy, and C. D. Lu. 2008. Transcriptome analysis of agmatine and putrescine catabolism in Pseudomonas aeruginosa PAO1. J Bacteriol 190:1966-1975. 11.D'Autreaux, B., and M. B. Toledano. 2007. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8:813-824. 12.Davies, J., and B. D. Davis. 1968. Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics. The effect of drug concentration. J Biol Chem 243:3312-3316. 13.de Lorenzo, V., M. Herrero, U. Jakubzik, and K. N. Timmis. 1990. Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria. J Bacteriol 172:6568-6572. 14.De Wulf, P., A. M. McGuire, X. Liu, and E. C. Lin. 2002. Genome-wide profiling of promoter recognition by the two-component response regulator CpxR-P in Escherichia coli. J Biol Chem 277:26652-26661. 15.Deby, C., and R. Goutier. 1990. New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases. Biochem Pharmacol 39:399-405. 16.Drechsel, H., A. Thieken, R. Reissbrodt, G. Jung, and G. Winkelmann. 1993. Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases. J Bacteriol 175:2727-2733. 17.Dwyer, D. J., M. A. Kohanski, and J. J. Collins. 2009. Role of reactive oxygen species in antibiotic action and resistance. Curr Opin Microbiol 12:482-489. 18.El'Garch, F., K. Jeannot, D. Hocquet, C. Llanes-Barakat, and P. Plesiat. 2007. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 51:1016-1021. 19.Fraimow, H. S., J. B. Greenman, I. M. Leviton, T. J. Dougherty, and M. H. Miller. 1991. Tobramycin uptake in Escherichia coli is driven by either electrical potential or ATP. J Bacteriol 173:2800-2808. 20.Fukuoka, T., N. Masuda, T. Takenouchi, N. Sekine, M. Iijima, and S. Ohya. 1991. Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob Agents Chemother 35:529-532. 21.Furness, R. B., G. M. Fraser, N. A. Hay, and C. Hughes. 1997. Negative feedback from a Proteus class II flagellum export defect to the flhDC master operon controlling cell division and flagellum assembly. J Bacteriol 179:5585-5588. 22.Girgis, H. S., A. K. Hottes, and S. Tavazoie. 2009. Genetic architecture of intrinsic antibiotic susceptibility. PLoS One 4:e5629. 23.Gulmezian, M., K. R. Hyman, B. N. Marbois, C. F. Clarke, and G. T. Javor. 2007. The role of UbiX in Escherichia coli coenzyme Q biosynthesis. Arch Biochem Biophys 467:144-153. 24.Ha, H. C., N. S. Sirisoma, P. Kuppusamy, J. L. Zweier, P. M. Woster, and R. A. Casero, Jr. 1998. The natural polyamine spermine functions directly as a free radical scavenger. Proc Natl Acad Sci U S A 95:11140-11145. 25.Hirakawa, H., Y. Inazumi, T. Masaki, T. Hirata, and A. Yamaguchi. 2005. Indole induces the expression of multidrug exporter genes in Escherichia coli. Mol Microbiol 55:1113-1126. 26.Igarashi, K., and K. Kashiwagi. 2000. Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun 271:559-564. 27.Imlay, J. A. 2003. Pathways of oxidative damage. Annu Rev Microbiol 57:395-418. 28.Imlay, J. A., S. M. Chin, and S. Linn. 1988. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240:640-642. 29.Iuchi, S., D. Furlong, and E. C. Lin. 1989. Differentiation of arcA, arcB, and cpxA mutant phenotypes of Escherichia coli by sex pilus formation and enzyme regulation. J Bacteriol 171:2889-2893. 30.Jung, I. L., and I. G. Kim. 2003. Transcription of ahpC, katG, and katE genes in Escherichia coli is regulated by polyamines: polyamine-deficient mutant sensitive to H2O2-induced oxidative damage. Biochem Biophys Res Commun 301:915-922. 31.Karlowsky, J. A., M. H. Saunders, G. A. Harding, D. J. Hoban, and G. G. Zhanel. 1996. In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 40:1387-1393. 32.Kohanski, M. A., D. J. Dwyer, and J. J. Collins. 2010. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8:423-435. 33.Kohanski, M. A., D. J. Dwyer, B. Hayete, C. A. Lawrence, and J. J. Collins. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. 34.Kohanski, M. A., D. J. Dwyer, J. Wierzbowski, G. Cottarel, and J. J. Collins. 2008. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135:679-690. 35.Kwon, D. H., and C. D. Lu. 2007. Polyamine effects on antibiotic susceptibility in bacteria. Antimicrob Agents Chemother 51:2070-2077. 36.Kwon, D. H., and C. D. Lu. 2006. Polyamines induce resistance to cationic peptide, aminoglycoside, and quinolone antibiotics in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 50:1615-1622. 37.Lee, P. C., R. Petri, B. N. Mijts, K. T. Watts, and C. Schmidt-Dannert. 2005. Directed evolution of Escherichia coli farnesyl diphosphate synthase (IspA) reveals novel structural determinants of chain length specificity. Metab Eng 7:18-26. 38.Lee, P. C., C. Salomon, B. Mijts, and C. Schmidt-Dannert. 2008. Biosynthesis of ubiquinone compounds with conjugated prenyl side chains. Appl Environ Microbiol 74:6908-6917. 39.Lerner, S. A., R. Seligsohn, and G. J. Matz. 1977. Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. Am J Med 62:919-923. 40.Li, X., D. E. Johnson, and H. L. Mobley. 1999. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis. Infect Immun 67:2822-2833. 41.Lois, L. M., N. Campos, S. R. Putra, K. Danielsen, M. Rohmer, and A. Boronat. 1998. Cloning and characterization of a gene from Escherichia coli encoding a transketolase-like enzyme that catalyzes the synthesis of D-1-deoxyxylulose 5-phosphate, a common precursor for isoprenoid, thiamin, and pyridoxol biosynthesis. Proc Natl Acad Sci U S A 95:2105-2110. 42.Meltzer, M., S. Hasenbein, N. Mamant, M. Merdanovic, S. Poepsel, P. Hauske, M. Kaiser, R. Huber, T. Krojer, T. Clausen, and M. Ehrmann. 2009. Structure, function and regulation of the conserved serine proteases DegP and DegS of Escherichia coli. Res Microbiol 160:660-666. 43.Michan, C., M. Manchado, G. Dorado, and C. Pueyo. 1999. In vivo transcription of the Escherichia coli oxyR regulon as a function of growth phase and in response to oxidative stress. J Bacteriol 181:2759-2764. 44.Mobley, H. L., R. Belas, V. Lockatell, G. Chippendale, A. L. Trifillis, D. E. Johnson, and J. W. Warren. 1996. Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Infect Immun 64:5332-5340. 45.Mobley, H. L., G. R. Chippendale, K. G. Swihart, and R. A. Welch. 1991. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells. Infect Immun 59:2036-2042. 46.Mobley, H. L., M. D. Island, and R. P. Hausinger. 1995. Molecular biology of microbial ureases. Microbiol Rev 59:451-480. 47.Nikaido, H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593-656. 48.Paez, P. L., M. C. Becerra, and I. Albesa. 2010. Effect of the association of reduced glutathione and ciprofloxacin on the antimicrobial activity in Staphylococcus aureus. FEMS Microbiol Lett 303:101-105. 49.Patel, C. N., B. W. Wortham, J. L. Lines, J. D. Fetherston, R. D. Perry, and M. A. Oliveira. 2006. Polyamines are essential for the formation of plague biofilm. J Bacteriol 188:2355-2363. 50.Poole, K. 2005. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49:479-487. 51.Rauprich, O., M. Matsushita, C. J. Weijer, F. Siegert, S. E. Esipov, and J. A. Shapiro. 1996. Periodic phenomena in Proteus mirabilis swarm colony development. J Bacteriol 178:6525-6538. 52.Recht, M. I., S. Douthwaite, and J. D. Puglisi. 1999. Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J 18:3133-3138. 53.Schurek, K. N., A. K. Marr, P. K. Taylor, I. Wiegand, L. Semenec, B. K. Khaira, and R. E. Hancock. 2008. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 52:4213-4219. 54.Schweizer, H. P., and T. T. Hoang. 1995. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa. Gene 158:15-22. 55.Seaver, L. C., and J. A. Imlay. 2001. Alkyl hydroperoxide reductase is the primary scavenger of endogenous hydrogen peroxide in Escherichia coli. J Bacteriol 183:7173-7181. 56.Setsukinai, K., Y. Urano, K. Kakinuma, H. J. Majima, and T. Nagano. 2003. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 278:3170-3175. 57.Shaw, K. J., P. N. Rather, R. S. Hare, and G. H. Miller. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57:138-163. 58.Silverblatt, F. J., and I. Ofek. 1978. Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis. J Infect Dis 138:664-667. 59.Stevenson, L. G., and P. N. Rather. 2006. A novel gene involved in regulating the flagellar gene cascade in Proteus mirabilis. J Bacteriol 188:7830-7839. 60.Stickler, D., N. Morris, M. C. Moreno, and N. Sabbuba. 1998. Studies on the formation of crystalline bacterial biofilms on urethral catheters. Eur J Clin Microbiol Infect Dis 17:649-652. 61.Sturgill, G., and P. N. Rather. 2004. Evidence that putrescine acts as an extracellular signal required for swarming in Proteus mirabilis. Mol Microbiol 51:437-446. 62.Taber, H. W., J. P. Mueller, P. F. Miller, and A. S. Arrow. 1987. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 51:439-457. 63.Tabor, C. W., and H. Tabor. 1985. Polyamines in microorganisms. Microbiol Rev 49:81-99. 64.Tkachenko, A., L. Nesterova, and M. Pshenichnov. 2001. The role of the natural polyamine putrescine in defense against oxidative stress in Escherichia coli. Arch Microbiol 176:155-157. 65.Vogt, S. L., A. Z. Nevesinjac, R. M. Humphries, M. S. Donnenberg, G. D. Armstrong, and T. L. Raivio. 2010. The Cpx envelope stress response both facilitates and inhibits elaboration of the enteropathogenic Escherichia coli bundle-forming pilus. Mol Microbiol 76:1095-1110. 66.Walker, K. E., S. Moghaddame-Jafari, C. V. Lockatell, D. Johnson, and R. Belas. 1999. ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells. Mol Microbiol 32:825-836. 67.Wallace, H. M., A. V. Fraser, and A. Hughes. 2003. A perspective of polyamine metabolism. Biochem J 376:1-14. 68.Warren, J. W., J. H. Tenney, J. M. Hoopes, H. L. Muncie, and W. C. Anthony. 1982. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 146:719-723. 69.Weinstein, M. J., G. M. Luedemann, E. M. Oden, G. H. Wagman, J. P. Rosselet, J. A. Marquez, C. T. Coniglio, W. Charney, H. L. Herzog, and J. Black. 1963. Gentamicin, a New Antibiotic Complex from Micromonospora. J Med Chem 6:463-464. 70.Wolfe, A. J., N. Parikh, B. P. Lima, and B. Zemaitaitis. 2008. Signal integration by the two-component signal transduction response regulator CpxR. J Bacteriol 190:2314-2322. 71.Wu, Y., and F. W. Outten. 2009. IscR controls iron-dependent biofilm formation in Escherichia coli by regulating type I fimbria expression. J Bacteriol 191:1248-1257. 72.Zheng, M., F. Aslund, and G. Storz. 1998. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 279:1718-1721. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41387 | - |
dc.description.abstract | Proteus mirabilis為革蘭氏陰性的腸內菌,一般在健康人類腸道屬於正常菌叢,不過在長期使用導尿管之病患身上,則會造成伺機性感染,嚴重甚至可能導致腎臟病、肺炎等併發症。
臨床上使用之gentamicin屬於aminoglycoside 類抗生素,常用於治療敗血症、嚴重尿道感染及院內呼吸道感染,但長期使用下會導致聽力受損及腎臟功能傷害等副作用。Gentamicin作用機制主要是當藥物進入細菌體內後,會和細菌的30S核醣體結合,導致核醣體發生mistranslation,進而造成細胞內蛋白質生成受到抑制,最終導致細菌死亡。然而,近期在E. coli的研究指出aminoglycoside藥物的作用機制不單只是和核醣體結合,會透過CpxA cross-talk至ArcA,進而影響細菌體內的代謝調控,導致hydroxyl radical等氧化壓力的大量產生而造成細菌死亡。 本篇論文首先利用跳躍子突變法 (transposon mutagenesis) 的方式,篩選出11株對gentamicin (Gm) 感受性改變的P. mirabilis突變株,其中10株對Gm感受性下降 (Gm-resistant突變株:cpxA、ispA、ubiD、pepP、nrpU、PMI1554、PMI2851、mutL、mutS和PMI0674),MIC數值皆比野生株高2 ~ 4倍;1株對Gm感受性增加 (Gm-susceptible突變株:speA),MIC數值比野生株低2倍。進一步發現當處理Gm後,Gm-resistant突變株生長情況和野生株並無差異或略為下降,且hydroxyl radical幾乎不會增加;而Gm-susceptible突變株生長會下降,hydroxyl radical則會增加。此外,若在Gm處理下額外添加抗氧化劑glutathione或iron chelator後,可顯著降低Gm誘發hydroxyl radical的生成。由此可證明,當P. mirabilis在Gm處理後,可能透過hydroxyl radical的生成導致細菌死亡。 在這些對Gm感受性改變的突變株中,我們也看見two-component system中的CpxA參與其中。為釐清Gm殺菌是否透過ArcA,故將arcA進行knockout,發現MIC數值比野生株高2倍,且hydroxyl radical生成較低,因此推測在P. mirabilis處理Gm後,也是循著CpxA-ArcA的殺菌途徑。 接著以real-time PCR方式測定,發現野生株在Gm處理後,ahpC、oxyR、sodA及sodB表現量上升,顯示Gm的確會造成氧化壓力增加;同時,acnA表現量上升,顯示Gm可透過影響TCA cycle和電子傳遞鏈表現,導致細菌內氧化壓力增加。然而這些指標在目前收集之10株P. mirabilis臨床菌株中並未觀察到顯著差異。此外,在Gm處理後cpxR的表現量會增加,同時在cpxA突變株中cpxR有過度表現的情況,由此推測CpxR可能對抵抗Gm扮演某種程度的角色尚待釐清。 另一方面,ubiquinone生合成相關之ispA和ubiD基因也參與其中,與能量生成有關。藉由電子傳遞鏈抑制劑CCCP來降低細菌體內能量的生成,發現野生株對Gm的抗性增加了2倍,而ispA和ubiD突變株則並無改變,由此可間接推測在P. mirabilis中Gm的吸收是需要能量的。 唯一挑到對Gm感受性增加的speA基因,參與細菌體內polyamine合成途徑。首先我們也發現speA突變株對於H2O2的感受性增加,進一步利用reporter assay得知oxyR的表現量比野生株略低。因此推測polyamine可透過影響OxyR的表現來影響對氧化壓力的抵抗性,進而影響到對Gm的感受性。 最後在毒力因子分析方面,cpxA突變株swarming較野生株緩慢;ispA和ubiD突變株的生長速度較為緩慢,連帶也使得swarming的速度較慢;cpxA和ispA突變株在haemolysin cycle中比野生株緩慢;speA的突變株swarming能力下降,同時haemolysin activity也較低。ispA、speA突變株之outer membrane protein以及其他菌株在swimming、biofilm的結果中,皆和野生株並無顯著差異。 總結,本研究證實了在P. mirabilis中,gentamicin可經由CpxA-ArcA途徑,透過hydroxyl radical的生成,而達到殺菌之功效。此外,透過降低細菌體內能量的生成以及polyamine含量的高低可協助細菌抵抗gentamicin殺菌。 | zh_TW |
dc.description.abstract | Proteus mirabilis is a facultative Gram-negative bacterium and a member of the Enterobacteriaceae family. It commonly causes urinary tract infection (UTI), and leads to kidney disease, pneumonia and septicemia in individuals with long-term catheterization or with structural or functional abnormalities in the urinary tract.
Gentamicin (Gm) is a kind of aminoglycoside antibiotics, which is commonly used in treatment of septicemia, severe urinary tract infections and nosocomial respiratory infections. It potentially damages the ears and kidney once given for a long period of time. Gentamicin could directly target the 30S subunit of ribosome, leading to protein mistranslation and cell death. Recently, studies in E. coli have suggested that the mechanism of aminoglycoside-lethality is a function of more than ribosome inhibition and may be due to disorders of multiple cellular metabolic targets through CpxA-ArcA pathway, triggering oxidative stress and cell death. In order to know the mechanisms of gentamicin killing in P. mirabilis, we performed transposon mutagenesis and 11 mutants were identified. Ten mutants were 2 to 4-fold more resistant (Gm-resistant mutants: cpxA、ispA、ubiD、pepP、nrpU、PMI1554、PMI2851、mutL、mutS and PMI0674), and one mutant was 2-fold more sensitive (Gm-susceptible mutant: speA) than the wild-type. We observed that in the present of gentamicin, Gm-resistant mutants had higher survival rates and less hydroxyl radical formation than wild-type. On the contrary, Gm-susceptible mutants had lower survival rates and more hydroxyl radical formation. We also observed that addition of glutathione or iron chelator significantly reduced hydroxyl radical formation in Gm-exposed strains, confirming that gentamicin killing in P. mirabilis is through hydroxyl radical formation. Knowing that CpxA, the sensor kinase of Cpx two-component system, is involved in gentamicin killing, we knockout arcA gene to determine the role of ArcA, another member of two-component system, in gentamicin killing. We observed that arcA mutant was 2-fold more resistant to Gm than wild-type and had less hydroxyl radical formation. These results imply that both CpxA and ArcA are associated with gentamicin killing. Moreover, we used real-time PCR to examine expression of oxidative stress-related genes following Gm treatment. We observed that the expression of ahpC, oxyR, sodA and sodB genes were activated after gentamicin treatment, indicating that cellular oxidative stress responses were triggered by gentamicin exposure. We also observed that the expression of acnA gene was activated, and nuoF was inhibited slightly, indicating that gentamicin-mediated disorders in TCA cycle and electron transfer chain may lead to oxidative stress. However, the expression of these oxidative stress-related genes showed no significant difference in the 10 clinical isolates of P. mirabilis. Besides, cpxR gene was activated after gentamicin treatment and overexpression of cpxR gene in cpxA mutant was observed, implying the protective role of CpxR in the present of gentamicin. We found ispA and ubiD genes which were related to ubiquinone biosynthesis and cellular energy production are also involved in Gm susceptibility. By addition of CCCP, an electron transfer chain inhibitor, we observed 2-fold more resistant to Gm in wild-type but not in ispA and ubiD mutants, suggesting that the gentamicin uptake is energy-dependent in P. mirabilis. The only Gm-susceptible mutant is speA gene, which is involved in polyamine biosynthesis. We observed that speA mutant was more sensitive to H2O2 than wild-type. We also found that the expression of oxyR gene (a regulator for H2O2 stress) in speA mutant was decreased by using reporter assay, suggested that polyamine may protect P. mirabilis from oxidative stress possibly through OxyR pathway. Finally, we assayed the virulence factors of these mutants. We found that cpxA mutant exhibited decreased swarming mobility. Due to the growth defect in ispA and ubiD mutants, decreased swarming mobility was found. In haemolysin assay, cpxA and ispA mutant had delayed cycle of haemolysin expression. Besides, speA mutant exhibited decreased swarming mobility and decreased haemolysin ability. No significant difference of swimming, biofilm formation and outer membrane proteins was observed between wild-type and the mutants. In conclusion, we found that gentamicin may affect multiple metabolic targets in P. mirabilis through CpxA-ArcA pathway, triggering hydroxyl radical formation and leading to cell death. In addition, we found that diminished energy production and the presence of polyamines may protect cells from gentamicin killing. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T00:17:51Z (GMT). No. of bitstreams: 1 ntu-100-R98424017-1.pdf: 2547301 bytes, checksum: ee393f867ed12cb103e3010812f09029 (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 口委審定書
致謝 i 目錄 ii 摘要 viii Abstract x 第一章 緒論 1 第一節 奇異變形桿菌 (Proteus mirabilis) 介紹 1 第二節 Gentamicin簡介及殺菌機轉介紹 5 第三節 研究動機與目的 9 第四節 實驗設計 10 第二章 實驗材料與方法 11 第一節 實驗材料 11 第二節 跳躍子卡匣突變方法 (transposon mutagenesis) 13 第三節 突變基因之鑑定 17 第四節 cpxA和arcA knockout方法 23 第五節 氧化壓力及gentamicin殺菌機制之分析 26 第六節 分析突變株毒力因子 (virulence factor) 表現 34 第三章 實驗結果 46 第一節 篩選出gentamicin感受性改變之突變株 46 第二節 突變株中自由基 (free radical) 的偵測 48 第三節 探討two-component system如何參與gentamicin殺菌 51 第四節 Gentamicin對臨床菌株作用機制探討 58 第五節 探討ubiquinone biosynthesis如何參與gentamicin殺菌 61 第六節 探討polyamine biosynthesis如何參與gentamicin殺菌 62 第七節 突變株毒力因子表現之分析 64 第四章 結論與討論 67 第一節 結論 67 第二節 雙組成系統與Gm殺菌的關係 70 第三節 能量代謝與Gm殺菌的關係 72 第四節 Polyamine與Gm殺菌的關係 73 第五節 其他基因對Gm殺菌的關係 74 第五章 表 75 第六章 圖 87 第七章 附錄 121 參考文獻 133 | |
dc.language.iso | zh-TW | |
dc.title | Gentamicin毒殺奇異變形桿菌之機制探討 | zh_TW |
dc.title | Genetic determinants associated with gentamicin killing in Proteus mirabilis | en |
dc.type | Thesis | |
dc.date.schoolyear | 99-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 鄧麗珍,賴信志,薛博仁 | |
dc.subject.keyword | 奇異變形桿菌,自由基,Cpx雙組成系統, | zh_TW |
dc.subject.keyword | Proteus mirabilis,free radical,Cpx two-component system,gentamicin, | en |
dc.relation.page | 138 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2011-08-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 醫學檢驗暨生物技術學研究所 | zh_TW |
顯示於系所單位: | 醫學檢驗暨生物技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 2.49 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。